Genprex, Inc. Gains 39.07%

Tue 07 Jan 20 at 05:30 PM
Genprex, Inc. Gains 39.07%

Genprex, Inc. (GNPX:NASDAQ) soared at $0.42, representing a gain of 39.1%. On Mon 06 Jan 20, GNPX:NASDAQ touched a New 2-Week Intraday High of $0.33. The stock got featured on our News Catalysts scanner on Mon 06 Jan 20 at 08:36 AM in the 'MISCELLANEOUS' category. From Fri 13 Dec 19, the stock recorded 50.00% Up Days and 33.33% Green Days

The share price of the company has been moving sideways in recent weeks.

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.